6-K ·Filed Aug 10, 2026
Notable filing: 6-K
Actionable Insight • Neutral
Monitor for subsequent ASX announcements regarding the outcome of the securities quotation application. No immediate trading catalyst.
Latest settled — T+20d
ATHE ▼ -0.88% at T+20d
NEUTRAL call -0.88% · α vs SPY +0.04% · entry $4.55 → $4.51
Latest observation: T+53 -47.57% FF3 residual α
T+1d
+3.30%
call +3.30% · α +3.62%
$4.70
settled 3mo ago
T+5d
+0.44%
call +0.44% · α +0.49%
$4.57
settled 2mo ago
T+20d
-0.88%
call -0.88% · α +0.04%
$4.51
settled 7w ago
T+60d
Pending
in 7d
Price Chart
Loading chart...
Executive Summary
Alterity Therapeutics filed a Form 6-K with an exhibit for an application to quote securities (ATH) on the Australian Securities Exchange. This is a routine administrative filing with no financial data or material business developments.
Key Facts
- Filed Form 6-K on August 10, 2026, for the month of August 2026.
- Exhibit 99.1 is an application for quotation of securities (ATH) on the ASX.
- The filing is incorporated by reference into existing S-8 and F-3 registration statements.
- No financial results, guidance, or material corporate events disclosed.
Financial Impact
No financial impact from this administrative filing.
Risk Factors
- No material risks identified from this filing.
Market Snapshot
Exchange
OTC
Sector
Pharmaceutical Preparations
Analyst Consensus
80% bullish (5 analysts)
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001437749-26-026626 |
| Document: 0001437749-26-026626-index-headers.html | 0001437749-26-026626 |
| Document: 0001437749-26-026626-index.html | 0001437749-26-026626 |
| Document: 0001437749-26-026626.txt | 0001437749-26-026626 |
42 reports for ATHE
67% Hit rate @ T+60 Went positive at some point 10 of 10 best @ T+20▲ +27.97%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 23, 2026 4d ago | 6-K | $2.09 | awaiting T+60 | — | $2.08 (+0.48%) |
Oct 23, 2026 4d ago | 6-K | $2.09 | awaiting T+60 | — | $2.08 (−0.48%) |
Oct 23, 2026 4d ago | 6-K | $2.09 | awaiting T+60 | — | $2.08 (−0.48%) |
Oct 21, 2026 6d ago | 6-K | $2.39 | awaiting T+60 | — | $2.08 (−12.97%) |
Oct 21, 2026 6d ago | 6-K | $2.39 | awaiting T+60 | — | $2.08 (−12.97%) |
Oct 19, 2026 8d ago | 6-K | $2.43 | awaiting T+60 | — | $2.08 (−14.40%) |
Oct 9, 2026 18d ago | 6-K | $3.12 | awaiting T+60 | — | $2.08 (−33.33%) |
Oct 5, 2026 22d ago | Press Release | $3.22 | awaiting T+60 | — | $2.08 (−35.40%) |
Oct 5, 2026 22d ago | 6-K | $3.22 | awaiting T+60 | — | $2.08 (−35.40%) |
Sep 25, 2026 4w ago | 6-K | $3.67 | awaiting T+60 | — | $2.08 (−43.32%) |
Showing 10 of 42
US Market Status
Market Closed — Opens in 5m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers